Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-based Combination Therapy
Clinical trial NCT07347314 · RECRUITING
Trial details
- NCT number
- NCT07347314
- Sponsor
- National Cancer Center, Japan
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-04
- Primary completion
- 2028-09-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.